Product type
Ticagrelor is an active pharmaceutical ingredient (API) used primarily as an antiplatelet medication to reduce the risk of cardiovascular events in patients with acute coronary syndrome. It works by inhibiting platelet activation and aggregation, thereby preventing blood clots. Ticagrelor is typically administered in oral form and is often prescribed alongside aspirin for enhanced efficacy in managing heart-related conditions.
| Chemical formula | C23H28F2N6O4S |
| Molecular weight | 522.57 g/mol |
| Form | Powder |
| Purity | Typically ≥ 98% |
| Storage conditions | Cool, dry place, away from light |
When selecting Ticagrelor as an API, buyers should consider the required purity levels and the specific formulation needs for their end products. It is important to specify the desired quantities and any relevant regulatory compliance or certifications required for pharmaceutical use. Buyers should also inquire about the supplier's quality assurance processes and stability data to ensure product reliability.
Get quotes for Ticagrelor
Tell us your requirement — quantity, specs and timeline — and our team sources verified manufacturers and brings you the best quote.
Ticagrelor is used to prevent blood clots in patients with acute coronary syndrome.
It inhibits platelet activation and aggregation, reducing the risk of cardiovascular events.
The typical purity is ≥ 98%.
It is typically available as a powder.
Store in a cool, dry place, away from light.
Yes, it is often prescribed alongside aspirin for enhanced effect.
It is used in cardiology, emergency medicine, and pharmaceutical manufacturing.
Specify purity, quantity, and any regulatory compliance needed.